Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort
The International Journal of Tuberculosis and Lung Disease, 06/22/2012
Clinical Article
Carroll MW et al. – Major adverse drug reactions are common during anti–tuberculosis chemotherapy in this population, occurring in more than one in six subjects. New and less toxic agents to treat drug–resistant tuberculosis are urgently needed.
